NCT05683392View on ClinicalTrials.gov

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

December 13, 2023

Study Completion Date

December 13, 2023

Conditions
Type 1 Diabetes
Interventions
DEVICE

t:slim X2 insulin pump with Control-IQ technology 2.0

t:slim X2 insulin pump with Control-IQ technology 2.0, and wearing the Dexcom G6 sensor.

Trial Locations (4)

22903

University of Virginia, Charlottesville

80045

Barbara Davis Center (Pediatric Clinic), Aurora

Barbara Davis Center, Aurora

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
lead

Tandem Diabetes Care, Inc.

INDUSTRY